| 1 |
Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, Rogers-Brown JS, Wester C, Nelson NP; Contributors. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023. MMWR Recomm Rep 2023;72:1-25. [PMID: 36893044 DOI: 10.15585/mmwr.rr7201a1] [Reference Citation Analysis]
|
| 2 |
Robinson A, Wong R, Gish RG. Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments. Clin Liver Dis 2023;27:17-25. [PMID: 36400464 DOI: 10.1016/j.cld.2022.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Shilib Al-shimmery AH, Abdul-abbas Bayram A, Obayes Al Mammori R, Al-khafaji NS, O.m. Al-dahmoshi H. Combined Interferon-Antiviral therapy effectiveness against Hepatitis B viral infection in Babylon Province. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00830] [Reference Citation Analysis]
|
| 4 |
Carry M, Bixler D, Weng MK, Doshani M, Roberts E, Montgomery MP. Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews. Harm Reduct J 2022;19:100. [PMID: 36050735 DOI: 10.1186/s12954-022-00681-x] [Reference Citation Analysis]
|
| 5 |
Aziz ur Rehman M, Kazim M, Ahmed N, Raza A, Rafiq M, Akgül A, Inc M, Park C, Zakarya M. Positivity preserving numerical method for epidemic model of hepatitis B disease dynamic with delay factor. Alexandria Engineering Journal 2022. [DOI: 10.1016/j.aej.2022.09.013] [Reference Citation Analysis]
|
| 6 |
Khan MA, Thompson WW, Osinubi A, Meyer 3rd WA, Kaufman HW, Armstrong PA, Foster MA, Nelson NP, Wester C. Trends in testing for hepatitis C during pregnancy among persons with Medicaid and commercial insurance, 2015–2019 (Preprint).. [DOI: 10.2196/preprints.40783] [Reference Citation Analysis]
|
| 7 |
Hall EW, Rosenberg ES, Jones CM, Asher A, Valverde E, Bradley H. Estimated number of injection-involved drug overdose deaths, United States, 2000 - 2018. Drug Alcohol Depend 2022;234:109428. [PMID: 35364419 DOI: 10.1016/j.drugalcdep.2022.109428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 8 |
Nagra N, Kozarek RA, Burman BE. Therapeutic Advances in Viral Hepatitis A-E. Adv Ther 2022;39:1524-52. [PMID: 35220557 DOI: 10.1007/s12325-022-02070-z] [Reference Citation Analysis]
|
| 9 |
Ozga JE, Paquette C, Syvertsen JL, Pollini RA. Mobile phone and internet use among people who inject drugs: Implications for mobile health interventions. Subst Abus 2022;43:592-7. [PMID: 34491889 DOI: 10.1080/08897077.2021.1975871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Chan K, Mangla N. Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States. Ann Hepatol 2022;27 Suppl 1:100576. [PMID: 34752949 DOI: 10.1016/j.aohep.2021.100576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Barnes E, Peacock J, Bachmann L. International Classification of Diseases (ICD) Codes Fail to Accurately Identify Injection Drug Use Associated Endocarditis Cases. J Addict Med 2022;16:27-32. [PMID: 35120064 DOI: 10.1097/ADM.0000000000000814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Marks LR, Reno H, Liang SY, Schwarz ES, Liss DB, Jiang L, Nolan NS, Durkin MJ. Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections. Open Forum Infect Dis 2021;8:ofab489. [PMID: 34926711 DOI: 10.1093/ofid/ofab489] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 13 |
Blackard JT, Sherman KE. Drugs of Abuse and Their Impact on Viral Pathogenesis. Viruses 2021;13:2387. [PMID: 34960656 DOI: 10.3390/v13122387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Roberts H, Ly KN, Yin S, Hughes E, Teshale E, Jiles R. Prevalence of HBV Infection, Vaccine-Induced Immunity, and Susceptibility Among At-Risk Populations: US Households, 2013-2018. Hepatology 2021;74:2353-65. [PMID: 34097776 DOI: 10.1002/hep.31991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Dekker SE, Green EW, Ahn J. Treatment and Prevention of Acute Hepatitis B Virus. Clin Liver Dis 2021;25:711-24. [PMID: 34593149 DOI: 10.1016/j.cld.2021.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Hall EW, Schillie S, Vaughan AS, Jones J, Bradley H, Lopman B, Rosenberg ES, Sullivan PS. County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017. Hepatology 2021;74:582-90. [PMID: 33609308 DOI: 10.1002/hep.31756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Kushner T, Chen Z, Tressler S, Kaufman H, Feinberg J, Terrault NA. Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States. Clin Infect Dis 2020;71:586-92. [PMID: 31504302 DOI: 10.1093/cid/ciz841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Ly KN, Xing J, Spradling PR. Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018. J Infect Dis 2021:jiab224. [PMID: 33903902 DOI: 10.1093/infdis/jiab224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Sarathy L, Cirillo C, Dehn C, Lerou PH, Prendergast M. Improving Timeliness of Hepatitis B Vaccine Birth Dose Administration. Hosp Pediatr 2021;11:446-53. [PMID: 33879503 DOI: 10.1542/hpeds.2020-002766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Kushner T, Kaplowitz E, Mei R, Xu C, Acker A, Rosenbluth E, Oredein I, Sarkar M, Terrault N, Bansal M, Forde KA. Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study. J Viral Hepat 2021;28:582-91. [PMID: 33372359 DOI: 10.1111/jvh.13459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Coyle JR, Freeland M, Eckel ST, Hart AL. Trends in Morbidity, Mortality, and Cost of Hospitalizations Associated With Infectious Disease Sequelae of the Opioid Epidemic. J Infect Dis 2020;222:S451-7. [PMID: 32877550 DOI: 10.1093/infdis/jiaa012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, Del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda. J Infect Dis 2020;222:S230-8. [PMID: 32877568 DOI: 10.1093/infdis/jiz673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 23 |
Tressler SR, Del Rosario MC, Kirby MD, Simmons AN, Scott MA, Ibrahim S, Forbi JC, Thai H, Xia GL, Lyman M, Collier MG, Patel PR, Bixler D. Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014. Infect Control Hosp Epidemiol 2021;:1-6. [PMID: 33641684 DOI: 10.1017/ice.2021.31] [Reference Citation Analysis]
|
| 24 |
Li A, Rosenthal ES, Rapoport AB, Rowley CF. Opioid use disorder and infectious complications in persons who inject drugs. Int Anesthesiol Clin 2020;58:4-11. [PMID: 32073421 DOI: 10.1097/AIA.0000000000000276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Wang S, Cohen C, Tang AS, Graham CS. Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions. Curr Hepatology Rep 2021;20:34-42. [DOI: 10.1007/s11901-020-00557-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Shing JZ, Ly KN, Xing J, Teshale EH, Jiles RB. Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20-59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001-2016. Clin Infect Dis 2020;70:2619-27. [PMID: 31350875 DOI: 10.1093/cid/ciz669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 27 |
Pollini RA, Paquette CE, Slocum S, LeMire D. 'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state. Addiction 2021;116:107-15. [PMID: 32415706 DOI: 10.1111/add.15113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 28 |
Akhtar WZ, Feinberg J. Opioid use disorder and rural America. The Opioid Epidemic and Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-68328-9.00003-5] [Reference Citation Analysis]
|
| 29 |
Zhou K, Terrault N. Opioid use disorder and Chronic Hepatitis B. The Opioid Epidemic and Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-68328-9.00007-2] [Reference Citation Analysis]
|
| 30 |
Pollini RA, Ozga JE, Blanchard D, Syvertsen JL. Consider the Source: Associations between Syringe Sources and Risky Injection Behaviors in California's Central Valley. Subst Use Misuse 2021;56:2007-16. [PMID: 34379030 DOI: 10.1080/10826084.2021.1963987] [Reference Citation Analysis]
|
| 31 |
Kim B, Terrault NA. Hepatitis B and Hepatitis D Infections in the Transplant Setting. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_37] [Reference Citation Analysis]
|
| 32 |
Farnsworth CW, Lloyd M, Jean S. Opioid Use Disorder and Associated Infectious Disease: The Role of the Laboratory in Addressing Health Disparities. J Appl Lab Med 2021;6:180-93. [PMID: 33438735 DOI: 10.1093/jalm/jfaa150] [Reference Citation Analysis]
|
| 33 |
Khouzam N, Gelberg L, Guo R, Tseng CH, Bhattacharya D. Opiate Dependence: A Risk Factor for Hepatitis B Virus Exposure in Homeless Adults. Fam Community Health 2020;43:161-9. [PMID: 32079972 DOI: 10.1097/FCH.0000000000000246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 34 |
Rosenthal EM, Hall EW, Rosenberg ES, Harris A, Nelson NP, Schillie S. Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine 2020;38:8206-15. [PMID: 33160756 DOI: 10.1016/j.vaccine.2020.10.067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 35 |
Tressler S, Lilly C, Gross D, Hulsey T, Feinberg J. Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia. Am J Prev Med 2020;59:e189-96. [PMID: 33012623 DOI: 10.1016/j.amepre.2020.05.022] [Reference Citation Analysis]
|
| 36 |
Tressler SR, Kushner T, Bhandari R. Factors Associated With Hepatitis B Exposure Among People Who Report Using Methamphetamine: National Health and Nutrition Examination Survey 2009-2016. J Infect Dis 2020;221:243-50. [PMID: 31504660 DOI: 10.1093/infdis/jiz445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 37 |
Watts T, Stockman L, Martin J, Guilfoyle SM, Vergeront JM, Zahner S. Estimates of Prenatal HIV, Hepatitis B Virus, and Hepatitis C Virus Testing Among Pregnant People Enrolled in Wisconsin Medicaid, 2011-2015. Matern Child Health J 2020;24:177-85. [PMID: 31834607 DOI: 10.1007/s10995-019-02841-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 38 |
Moraras K, Block J, Shiroma N, Cannizzo A, Cohen C. Protecting the Rights of Health Care Students Living With Hepatitis B Under the Americans With Disabilities Act. Public Health Rep 2020;135:13S-8S. [PMID: 32735187 DOI: 10.1177/0033354920921252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 39 |
Lloyd M, Farnsworth CW. The Opioid Epidemic: Associated Infections and Diagnostic Methods. Clinical Microbiology Newsletter 2020;42:145-155. [DOI: 10.1016/j.clinmicnews.2020.08.003] [Reference Citation Analysis]
|
| 40 |
Freeland C, Ventricelli DJ. The Role of the Pharmacist in Preventing Hepatitis B in the Context of the Opioid Crisis. Prev Chronic Dis 2020;17:E88. [PMID: 32816663 DOI: 10.5888/pcd17.200062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 41 |
Heimer R, Hawk K, Vermund SH. Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses. Clin Infect Dis 2019;69:546-51. [PMID: 30452633 DOI: 10.1093/cid/ciy977] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 42 |
Figgatt M, Hildick-Smith J, Addish E, Coleman J, Benitez J, Freeland C, Alles S, Viner K, Johnson C, Kuncio D. Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018. Public Health Rep 2020;135:691-9. [PMID: 32791034 DOI: 10.1177/0033354920943528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Jia Q, Yu F, Zhou Q, Chen X, Gu Z, Ma C. Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine. Exp Ther Med 2020;20:1709-15. [PMID: 32742400 DOI: 10.3892/etm.2020.8859] [Reference Citation Analysis]
|
| 44 |
Tressler SR, Smith GS, Hendricks BM. Impact of a vaccine intervention on county-level rates of acute hepatitis B in West Virginia, 2011-2018. Prev Med 2020;137:106121. [PMID: 32389678 DOI: 10.1016/j.ypmed.2020.106121] [Reference Citation Analysis]
|
| 45 |
Hwang JP, Feld JJ, Hammond SP, Wang SH, Alston-Johnson DE, Cryer DR, Hershman DL, Loehrer AP, Sabichi AL, Symington BE, Terrault N, Wong ML, Somerfield MR, Artz AS. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.J Clin Oncol. 2020;38:3698-3715. [PMID: 32716741 DOI: 10.1200/JCO.20.01757] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
|
| 46 |
Johansson ED, Nunez M. Acute Hepatitis B Surge: Opioid Epidemic Implication and Management Challenges. Open Forum Infect Dis 2020;7:ofaa190. [PMID: 32550238 DOI: 10.1093/ofid/ofaa190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
Geirsson A, Schranz A, Jawitz O, Mori M, Feng L, Zwischenberger BA, Iribarne A, Dearani J, Rushing G, Badhwar V, Crestanello JA. The Evolving Burden of Drug Use Associated Infective Endocarditis in the United States. Ann Thorac Surg 2020;110:1185-92. [PMID: 32387035 DOI: 10.1016/j.athoracsur.2020.03.089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 48 |
Blackard JT, Brown JL, Lyons MS. Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda. Curr HIV Res 2019;17:94-101. [PMID: 31210115 DOI: 10.2174/1570162X17666190618154534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 49 |
Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: A concise review. J Neurol Sci 2020;411:116719. [PMID: 32070807 DOI: 10.1016/j.jns.2020.116719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 50 |
Kim B, Terrault NA. Hepatitis B and Hepatitis D Infections in the Transplant Setting. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_37-1] [Reference Citation Analysis]
|
| 51 |
Tressler S, Bhandari R. Interventions to Increase Completion of Hepatitis B Vaccination in People who Inject Drugs: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2019;6:ofz521. [PMID: 31890724 DOI: 10.1093/ofid/ofz521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 52 |
Syvertsen JL, Pollini RA. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley. Int J Drug Policy 2020;75:102594. [PMID: 31775079 DOI: 10.1016/j.drugpo.2019.10.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 53 |
Beheshti D. Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin. Health Econ 2019;28:1449-61. [PMID: 31715653 DOI: 10.1002/hec.3944] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
Chang MH, Moonesinghe R, Schieber LZ, Truman BI. Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015. J Clin Med 2019;8:E1768. [PMID: 31652928 DOI: 10.3390/jcm8111768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 55 |
Koepke R, Sill DN, Akhtar WZ, Mitchell KP, Guilfoyle SM, Westergaard RP, Schauer SL, Vergeront JM. Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection. Public Health Rep 2019;134:651-9. [PMID: 31539482 DOI: 10.1177/0033354919874088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 56 |
Bixler D, Annambholta P, Abara WE, Collier MG, Jones J, Mixson-Hayden T, Basavaraju SV, Ramachandran S, Kamili S, Moorman A. Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017. Am J Transplant 2019;19:2570-82. [PMID: 30861300 DOI: 10.1111/ajt.15352] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 57 |
Hyer RN, Janssen RS. Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70 years. Vaccine 2019;37:5854-61. [PMID: 31431412 DOI: 10.1016/j.vaccine.2019.08.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 58 |
Verna EC, Schluger A, Brown RS Jr. Opioid epidemic and liver disease. JHEP Rep 2019;1:240-55. [PMID: 32039374 DOI: 10.1016/j.jhepr.2019.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 59 |
Alhazmi RA, Parker RD, Wen S. Needlestick Injuries Among Emergency Medical Services Providers in Urban and Rural Areas. J Community Health 2018;43:518-23. [PMID: 29129032 DOI: 10.1007/s10900-017-0446-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 60 |
Teshale EH, Asher A, Aslam MV, Augustine R, Duncan E, Rose-Wood A, Ward J, Mermin J, Owusu-Edusei K, Dietz PM. Estimated cost of comprehensive syringe service program in the United States. PLoS One 2019;14:e0216205. [PMID: 31026295 DOI: 10.1371/journal.pone.0216205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 61 |
Yeo YH, Le MH, Chang ET, Henry L, Nguyen MH. Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection. Hepatology 2019;69:1385-97. [PMID: 30246260 DOI: 10.1002/hep.30285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 62 |
Rosenthal E, Baden R. Hepatitis B: The Western Perspective. Clinical Epidemiology of Chronic Liver Diseases 2019. [DOI: 10.1007/978-3-319-94355-8_10] [Reference Citation Analysis]
|
| 63 |
Borah A, Nath B. Identifying risk factors for adverse diseases using dynamic rare association rule mining. Expert Systems with Applications 2018;113:233-63. [DOI: 10.1016/j.eswa.2018.07.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 64 |
Schaffner W, Nichol KL, Reingold AL. Preventing Hepatitis B in US Adults Through Vaccination. Infect Dis Clin Pract 2018;26:304-312. [DOI: 10.1097/ipc.0000000000000685] [Reference Citation Analysis]
|
| 65 |
Wilson P, Taylor G, Knowles J, Blyth E, Laux J, Lohr J, Jhaveri R. Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months. J Infect 2019;78:134-9. [PMID: 30292782 DOI: 10.1016/j.jinf.2018.09.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 66 |
Kim BY, Patel JJ, Steele RW. Communication Between Obstetricians and Pediatricians. Clin Pediatr (Phila) 2018;57:1373-7. [PMID: 29616600 DOI: 10.1177/0009922818768293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 67 |
Bath RM, Doering BE, Nailor MD, Goodlet KJ. Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Ann Pharmacother 2019;53:294-310. [PMID: 30203666 DOI: 10.1177/1060028018800501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 68 |
Kushner T, Sarkar M. Chronic Hepatitis B in Pregnancy. Clin Liver Dis (Hoboken) 2018;12:24-8. [PMID: 30988905 DOI: 10.1002/cld.727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 69 |
Hyun Kim B, Ray Kim W. Epidemiology of Hepatitis B Virus Infection in the United States. Clin Liver Dis (Hoboken) 2018;12:1-4. [PMID: 30988901 DOI: 10.1002/cld.732] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 70 |
Jhaveri R. Hot Topics in Viral Infections. Clin Ther 2018;40:1230-3. [PMID: 30093134 DOI: 10.1016/j.clinthera.2018.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 71 |
Freeland C, Cohen C, Collier MG. Public Health Response to Hepatitis B Exposure. Infect Dis Clin Pract 2018;26:185-186. [DOI: 10.1097/ipc.0000000000000656] [Reference Citation Analysis]
|
| 72 |
Barker KL, Galeota EY. Shining a LIGHT Into Drug Darkness. The Journal for Nurse Practitioners 2018;14:463-469.e3. [DOI: 10.1016/j.nurpra.2017.12.004] [Reference Citation Analysis]
|
| 73 |
Hyer R, Mcguire DK, Xing B, Jackson S, Janssen R. Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults. Vaccine 2018;36:2604-11. [DOI: 10.1016/j.vaccine.2018.03.067] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 74 |
Espinosa CM, Jhaveri R. Update on the management of hepatitis B and C infections in the neonatal period. Semin Perinatol 2018;42:185-90. [PMID: 29526383 DOI: 10.1053/j.semperi.2018.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 75 |
Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. World J Gastroenterol 2018; 24(11): 1216-1227 [PMID: 29568202 DOI: 10.3748/wjg.v24.i11.1216] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 76 |
Comer M, Matthias J, Nicholson G, Asher A, Holmberg S, Wilson C. Notes from the Field: Increase in Acute Hepatitis B Infections - Pasco County, Florida, 2011-2016. MMWR Morb Mortal Wkly Rep 2018;67:230-1. [PMID: 29470456 DOI: 10.15585/mmwr.mm6707a6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 77 |
Goodin A, Fallin-Bennett A, Green T, Freeman PR. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange. Harm Reduct J 2018;15:4. [PMID: 29370808 DOI: 10.1186/s12954-018-0211-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 78 |
Sarah Schillie, Claudia Vellozzi, Arthur Reingold, Aaron Harris, Penina Haber, John W. Ward, Noele P. Nelson. Prevention of Hepatitis B Virus Infection in the United States:
Recommendations of the Advisory Committee on Immunization
Practices. MMWR Recomm Rep 2018;67. [PMID: 29939980 DOI: 10.15585/mmwr.rr6701a1] [Cited by in Crossref: 337] [Cited by in F6Publishing: 334] [Article Influence: 67.4] [Reference Citation Analysis]
|
| 79 |
Palmateer NE, Goldberg DJ, Munro A, Taylor A, Yeung A, Wallace LA, Mitchell A, Shepherd SJ, Gunson RN, Aitken C, Hutchinson SJ. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs. Addiction 2018;113:80-90. [PMID: 28710874 DOI: 10.1111/add.13944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 80 |
Jackson S, Lentino J, Kopp J, Murray L, Ellison W, Rhee M, Shockey G, Akella L, Erby K, Heyward WL, Janssen RS; HBV-23 Study Group. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine 2018;36:668-74. [PMID: 29289383 DOI: 10.1016/j.vaccine.2017.12.038] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 81 |
Higgins DC, Kuncio DE, Johnson CC, Viner KM. Influence of birth origin and risk factor profile on hepatitis B mortality: Philadelphia, PA 2003-2013. Ann Epidemiol 2018;28:169-74. [PMID: 29310975 DOI: 10.1016/j.annepidem.2017.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 82 |
Hutin Y, Low-Beer D, Bergeri I, Hess S, Garcia-Calleja JM, Hayashi C, Mozalevskis A, Rinder Stengaard A, Sabin K, Harmanci H. Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers. JMIR Public Health Surveill. 2017;3:e91. [PMID: 29246882 DOI: 10.2196/publichealth.7370] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 83 |
Kushner T, Lam R, Gray DL, Kaplan DE, Serper M. Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B. J Clin Gastroenterol 2017;51:900-6. [PMID: 28492425 DOI: 10.1097/MCG.0000000000000806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 84 |
Schaefer EA, Friedman LS. History Taking and Physical Examination for the Patient with Liver Disease. Schiff's Diseases of the Liver 2017. [DOI: 10.1002/9781119251316.ch1] [Reference Citation Analysis]
|
| 85 |
Schoenberg NE, Swanson M. Rural Religious Leaders' Perspectives on their Communities' Health Priorities and Health. South Med J 2017;110:447-51. [PMID: 28679012 DOI: 10.14423/SMJ.0000000000000671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 86 |
Liu J, Goicochea P, Block T, Brosgart CL, Donaldson EF, Lenz O, Gee Lim S, Marins EG, Mishra P, Peters MG, Miller V. Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation. Journal of Virus Eradication 2017;3:1-6. [DOI: 10.1016/s2055-6640(20)30302-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 87 |
Lenardson JD, Smith ML. Catastrophic Consequences: The Link Between Rural Opioid Use and HIV/AIDS. HIV/AIDS in Rural Communities 2017. [DOI: 10.1007/978-3-319-56239-1_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 88 |
Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. Clin Liver Dis 2016;20:607-28. [PMID: 27742003 DOI: 10.1016/j.cld.2016.06.006] [Cited by in Crossref: 168] [Cited by in F6Publishing: 173] [Article Influence: 24.0] [Reference Citation Analysis]
|
